http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CO-6321158-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bde28565d28f037e78bf4a67776ee24
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4965
filingDate 2011-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66710bbfa0ae5a6fa7d8963b396c0308
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f454c89dea5188e3f9f778a7ceaee5cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6691f08e6effbbcaf60f242e5c004fdf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f515e4221abba7cb731b798609dfe56a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efdc3480a460a6e49f48bb23a4236662
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7534cea6000c8719daa0abfd235a5a73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19a40e01e269091e9fd4f1bb5a76e6d3
publicationDate 2011-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CO-6321158-A2
titleOfInvention ORAL FORMULATION
abstract The invention relates to a pharmaceutical composition intended for oral administration comprising low doses of 4- ((1R, 3S) -6-chloro-3-phenylindan-1-yl) -1,2,2-trimethylpiperazine and a composition which comprises the compound.
priorityDate 2008-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419592315
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11465618

Total number of triples: 35.